In samples from patients with MM, all samples were negative for SRRM2 expression on granulocytes, monocytes, and lymphocytes in the newly diagnosed subgroup, the (VGPR + PR) subgroup, the PCL subgroup, and the CR subgroup. Here, SRRM2 is linked to Miyoshi myopathy.